To include your compound in the COVID-19 Resource Center, submit it here.
INDICATION: Viral hemorrhagic fever
Non-human primates studies suggest mAbs against Lassa virus glycoprotein could help prevent or treat Lassa fever. In
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury